Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Advanced and metastatic small bowel adenocarcinoma, drawn from the whole corpus: 1 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
No randomised phase 3 trial has ever been completed in advanced small bowel adenocarcinoma.
Nothing recorded yet.
Nothing recorded yet.
Background: Tumour-agnostic (tissue-agnostic) approval. Also on OnCo: Find a trial · Expert centres.
Mismatch-repair-proficient tumours have no effective immunotherapy.
Anti-EGFR and other colorectal targeted drugs do not translate.
Rarity makes trials slow and most evidence is retrospective.
Nothing recorded yet.
Nothing recorded yet.
Background: Tumour-agnostic (tissue-agnostic) approval. Also on OnCo: Find a trial · Expert centres.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 5 changes by month →When this page itself was last checked or edited.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.